Evidence map›Paper›PMID 34580619›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2021

Biomaterials and Oxygen Join Forces to Shape the Immune Response and Boost COVID-19 Vaccines.

Thibault Colombani, Loek J Eggermont, Zachary J Rogers, Lindsay G A McKay, Laura E Avena, Rebecca I Johnson, Nadia Storm, Anthony Griffiths, Sidi A Bencherif

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Hydrogel applications: a promising frontier in pneumonia therapy.Frontiers in bioengineering and biotechnology · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Mitigating Metal-Organic Framework (MOF) Toxicity for Biomedical Applications.Chemical engineering journal (Lausanne, Switzerland : 1996) · 2023
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Thibault ColombaniDepartment of Chemical Engineering Northeastern University Boston MA 02115 USA.
Loek J EggermontDepartment of Chemical Engineering Northeastern University Boston MA 02115 USA.
Zachary J RogersDepartment of Chemical Engineering Northeastern University Boston MA 02115 USA.
Lindsay G A McKayDepartment of Microbiology and National Emerging Infectious Diseases Laboratories Boston University School of Medicine Boston MA 02118 USA.
Laura E AvenaDepartment of Microbiology and National Emerging Infectious Diseases Laboratories Boston University School of Medicine Boston MA 02118 USA.
Rebecca I JohnsonDepartment of Microbiology and National Emerging Infectious Diseases Laboratories Boston University School of Medicine Boston MA 02118 USA.
Nadia StormDepartment of Microbiology and National Emerging Infectious Diseases Laboratories Boston University School of Medicine Boston MA 02118 USA.
Anthony GriffithsDepartment of Microbiology and National Emerging Infectious Diseases Laboratories Boston University School of Medicine Boston MA 02118 USA.
Sidi A BencherifDepartment of Chemical Engineering Northeastern University Boston MA 02115 USA.ORCID 0000-0002-7704-5608

Funding

Overcoming vaccine-associated hypoxia with advanced biomaterials to enhance cancer immunotherapyR01EB027705 · NIBIB · NORTHEASTERN UNIVERSITY · PI HATFIELD, STEPHEN MATTHEW · 2021 to 2024
$1.9M
NIBIB NIH HHS R01 EB027705
6 · The paper itself

Abstract

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has led to an unprecedented global health crisis, resulting in a critical need for effective vaccines that generate protective antibodies. Protein subunit vaccines represent a promising approach but often lack the immunogenicity required for strong immune stimulation. To overcome this challenge, it is first demonstrated that advanced biomaterials can be leveraged to boost the effectiveness of SARS-CoV-2 protein subunit vaccines. Additionally, it is reported that oxygen is a powerful immunological co-adjuvant and has an ability to further potentiate vaccine potency. In preclinical studies, mice immunized with an oxygen-generating coronavirus disease 2019 (COVID-19) cryogel-based vaccine (O

Indexed as

AnimalsBiocompatible MaterialsCOVID-19COVID-19 VaccinesCryogelsDrug Delivery SystemsFemaleImmunityMiceModels, AnimalOxygenSARS-CoV-2Biocompatible MaterialsCOVID-19 VaccinesCryogelsOxygenCOVID‐19injectable cryogelneutralizing antibodiesoxygensevere acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) vaccine

Identifiers

PMID34580619
PMCPMC8209904

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.